Al-Hariri Mohammed T, Al Goweiz Roaa, Aldhafery Bander, Alsadah Majed M, Alkathim Ahmed S, AlQassab Mohsen Z, AlRammadan Abdullah H, AlElaq Mahmoud A
Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Saudi Arabia.
Department of Radiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Saudi Arabia.
J Family Med Prim Care. 2021 Jan;10(1):533-537. doi: 10.4103/jfmpc.jfmpc_1872_20. Epub 2021 Jan 30.
Osteoporosis (OP) is a silent systemic disease characterized by decrements in bone mineral density (BMD) and bone microstructure. This study aimed to determine the status of bone quality as well as to investigate the relationship between the glycaemic; lipid; bone profiles; and the BMD.
A retrospective study was conducted at KFHU, Al Khobar, Saudi Arabia analysis of patients who underwent BMD testing between the periods of 2016 to 2018. Based on the T scores, patients were classified as follows: normal (>-1.0), osteopenic (-1.0 to -2.5), or osteoporotic (≤-2.5). Details about medical and demographic information as well as metabolic and bone profiles (fasting blood glucose [FBG], glycated haemoglobin [HbA1c], cholesterol [Chol], high-density lipoprotein [HDL], low-density lipoprotein [LDL], triglycerides [TG], calcium [Ca], phosphorus [Ph], alkaline phosphatase [ALP], vitamin D 25OHD [Vit D]) were extracted from the medical records system.
Out of 4838 extracted profiles, there were 4196 females (85.1%). The mean glycaemic variables of patients showed an abnormal profile (FBG 118 ± 49 and HbA1c 6.6 ± 2). The mean T score showed that the majority of patients had either osteopenic (40%) or osteoporotic (24%) changed. Significant increase in mean HbA1c (7.6 ± 1.7) was obvious among the osteopenic patients when judged against the normal (7.5 ± 1.6; < 0.033) and osteoporotic (7.4 ± 1.8; < 0.037). Meanwhile, the mean serum ALP was significantly lower (81 ± 26) in the normal group than in the osteopenic (86 ± 33; < 0.006) and osteoporotic groups (90 ± 40; < 0.001). Finally, a linear, logistic regression analysis was found that Ca and ALP levels were significant predictors.
This study finds that the main cause that affects bone quality in Saudi Arabia is diabetes mellitus and/or its related metabolic alteration. These results suggest that bone health is clinically significant and should be carefully assessed in diabetes patients.
骨质疏松症(OP)是一种隐匿性全身性疾病,其特征为骨矿物质密度(BMD)和骨微结构降低。本研究旨在确定骨质量状况,并调查血糖、血脂、骨代谢指标与骨密度之间的关系。
在沙特阿拉伯胡巴尔市的法赫德国王医院进行了一项回顾性研究,分析了2016年至2018年期间接受骨密度检测的患者。根据T值,将患者分类如下:正常(T值>-1.0)、骨量减少(T值-1.0至-2.5)或骨质疏松(T值≤-2.5)。从医疗记录系统中提取了有关医疗和人口统计学信息以及代谢和骨代谢指标(空腹血糖[FBG]、糖化血红蛋白[HbA1c]、胆固醇[Chol]、高密度脂蛋白[HDL]、低密度脂蛋白[LDL]、甘油三酯[TG]、钙[Ca]、磷[Ph]、碱性磷酸酶[ALP]、维生素D 25羟维生素D[Vit D])的详细信息。
在提取的4838份病历中,女性有4196例(85.1%)。患者的平均血糖指标显示异常(FBG为118±49,HbA1c为6.6±2)。平均T值显示,大多数患者存在骨量减少(40%)或骨质疏松(24%)改变。与正常组(7.5±1.6;P<0.033)和骨质疏松组(7.4±1.8;P<0.037)相比,骨量减少患者的平均HbA1c显著升高(7.6±1.7)。同时,正常组的平均血清ALP显著低于骨量减少组(86±33;P<0.006)和骨质疏松组(90±40;P<0.001)。最后,线性逻辑回归分析发现钙和ALP水平是显著的预测因素。
本研究发现,沙特阿拉伯影响骨质量的主要原因是糖尿病和/或其相关的代谢改变。这些结果表明,骨健康在临床上具有重要意义,糖尿病患者应仔细评估骨健康状况。